Prof. Sang Ho Choi
Seoul National University, South Korea
Email: choish@snu.ac.kr
Qualifications
1992 Ph.D., University of Iowa, College of Medicine, USA
1985 M.S., Korea Advanced Institute of Science and Technology, S. Korea
1982 B.A., Seoul National University, S. Korea
Publications (Selected)
-
Chang, E., Kim, J. W., Jang, C. Y., Kim, J. Y., Kang, S. W., Choi, S. H., ... & Kim, S. H. (2025). Predicting persistent SARS-CoV-2 shedding in immunocompromised patients: a probability-based approach. Infectious Diseases, 1-10.
-
Sung, D., Choi, G., Ahn, M., Byun, H., Kim, T. Y., Lee, H., ... & Choi, S. H. (2024). Genome-wide phenotypic profiling of transcription factors and identification of novel targets to control the virulence of Vibrio vulnificus. Nucleic Acids Research, gkae1238.
-
Park, K. H., Huh, J. W., Hong, S. B., Sung, H., Do, K. H., Lee, S. O., ... & Choi, S. H. (2024). Impact of Respiratory Co-Detection in Critically Ill Patients with Pneumocystis jirovecii Pneumonia. American Journal of Respiratory and Critical Care Medicine, (ja).
-
Choi, W., Lee, H., Wang, Q., Bang, Y. J., & Choi, S. H. (2024). Discovery of a Small-Molecule Inhibitor Targeting the Biofilm Regulator BrpT in Vibrio vulnificus. Journal of Microbiology and Biotechnology, 34(11), 2201.
-
Park, J. H., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2024). Severe Human Parainfluenza Virus Community-and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital, Seoul, South Korea, 2010–2019. Emerging Infectious Diseases, 30(6), 1088.
-
Park, J. H., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2023, November). 2645. Severe Human Parainfluenza Virus-associated Pneumonia in Adults, Seoul, South Korea, 2010-2019. In Open Forum Infectious Diseases (Vol. 10, No. Suppl 2, pp. ofad500-2257).
-
Lim, S. Y., Kwon, H. J., Lee, Y. W., Sung, H., Kim, M. N., Choi, S. H., ... & Chong, Y. P. (2023). Routine ophthalmologic examination in Klebsiella pneumoniae bacteremia is not necessary: incidence of and risk factors for ocular involvement. Antimicrobial Agents and Chemotherapy, 67(11), e00822-23.
-
Kim, Y. K., Eom, Y., Kim, E., Chang, E., Bae, S., Choi, S. H., ... & Kim, Y. S. (2023). Molecular characteristics and prevalence of rifampin resistance in Staphylococcus aureus isolates from patients with bacteremia in South Korea. Antibiotics, 12(10), 1511.
-
Han, J., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Choi, S. H., ... & Kim, S. H. (2023). Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study. Medicine, 102(39), e35094.
-
Kim, T., Hong, S. B., Huh, J. W., Jung, J., Kim, M. J., Chong, Y. P., ... & Choi, S. H. (2022, December). 2192. Clinical and Molecular Characteristics of Severe Respiratory Syncytial Virus Pneumonia in Critically Ill Adults. In Open Forum Infectious Diseases (Vol. 9, No. Supplement_2, pp. ofac492-1811). US: Oxford University Press.
-
Bae, M., Song, J. S., Kim, J. Y., Bae, S., Jung, J., Choi, S. H., ... & Kim, S. H. (2023). The relationship between organising pneumonia and invasive mould disease in patients with haematologic malignancy. Mycoses, 66(4), 289-298.
-
Kang, S. W., Kim, J. Y., Park, H., Lim, S. Y., Kim, J., Choi, S. H., ... & Kim, S. H. (2023). Comparison of secondary attack rate and viable virus shedding between patients with SARS‐CoV‐2 Delta and Omicron variants: a prospective cohort study. Journal of Medical Virology, 95(1), e28369.
-
Ko, D., & Choi, S. H. (2022). Mechanistic understanding of antibiotic resistance mediated by EnvZ/OmpR two-component system in Salmonella enterica serovar Enteritidis. Journal of Antimicrobial Chemotherapy, 77(9), 2419-2428.
Profile Details
https://food.snu.ac.kr/en/members/sang-ho-choi/?ckattempt=1
https://loop.frontiersin.org/people/527858/publications
https://www.researchgate.net/profile/Sang-Ho-Choi-4